TADAWUL:4016 Revenue

In the year 2025, Middle East Pharmaceutical Industries Company had annual revenue of 460.48M SAR with 16.87% growth. Middle East Pharmaceutical Industries Company had revenue of 137.52M in the quarter ending December 31, 2025, with 1.12% growth.

Revenue

460.48M

Revenue Growth

+16.87%

P/S Ratio

4.49

Revenue / Employee

629.94K

Employees

731

Market Cap

2.07B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	460.48M	66.48M	16.87%
Dec 31, 2024	394.00M	55.56M	16.42%
Dec 31, 2023	338.44M	35.78M	11.82%
Dec 31, 2022	302.66M	15.44M	5.38%
Dec 31, 2021	287.22M	-14.44M	-4.79%
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Dr. Sulaiman Al Habib Medical Services Group Company	13.71B
Mouwasat Medical Services Company	3.22B
Nahdi Medical Company	10.21B
Dallah Healthcare Company	4.07B
Specialized Medical Company	1.54B
Al-Dawaa Medical Services Company	6.75B
Al Hammadi Holding Company	1.23B
Saudi Pharmaceutical Industries and Medical Appliances	1.71B

Revenue Rankings